Morning Market Losers

Roka Bioscience

dipped 39.93% to $5.01 after the company reported Q3 results. Bank of America downgraded Roka Bioscience from Buy to Neutral. Salix Pharmaceuticals

shares tumbled 36.12% to $88.50 after the company reported downbeat Q3 results and appointed Timothy Creech as CFO. Analysts at Stifel Nicolaus downgraded Salix Pharma from Buy to Hold and removed the price target of $189. Financial Engines

dropped 25.36% to $30.47 after the company reported Q3 earnings of $0.23 per share on revenue of $72.80 million and appointed Lawrence Raffone as CEO. Amber Road

shares dipped 25.35% to $10.16 on Q3 results. Stifel Nicolaus lowered the price target on Amber Road from $19.00 to $18.00. Summer Infant

slipped 22.53% to $2.39 after the company reported Q3 earnings of $0.03 per share. The company appointed William E. Mote, Jr. as CFO and Annamaria Dooley as Senior Vice President of product development. Intercept Pharmaceuticals

shares dropped 17% to $205.01 after the company reported a Q3 loss of $1.69 per share and announced that results from the FLINT trial in nonalcoholic steatohepatitis (NASH) were published in The Lancet. Performant Financial

shares slipped 16.65% to $7.21 after the company reported downbeat Q3 results and lowered its FY14 revenue forecast. William Blair downgraded Performant Financial from Outperform to Market Perform. Allscripts Healthcare Solutions

shares fell 16.09% to $11.37 on downbeat Q3 earnings. Evercore Partners downgraded Allscripts Healthcare from Buy to Hold. Ubiquiti Networks

shares dipped 15.90% to $29.12 after the company reported weaker-than-expected FQ1 results and issued a downbeat Q2 outlook. Wunderlich lowered the price target on Ubiquiti Networks from $55.00 to $50.00. Fairway Group Holdings

declined 14.34% to $2.33 after the company reported a Q2 loss of $0.40 per share on revenue of $194.0 million. Credit Suisse lowered the price target on Fairway Group from $4.00 to $2.50. Abercrombie & Fitch Co

shares declined 12.21% to $31.06 after the company issued a downbeat profit outlook. Universal Display

tumbled 4.87% to $26.00 after the company reported Q3 earnings of $0.09 per share on revenue of $32.89 million.